JRNYS Wellness

JRNYS Wellness

Private
United StatesHealthcare & Life Scienceshttps://jrnys.com

Last Round

Seed Round

Apr 22, 2026

Total Funding Raised

$8.6M

Momentum Score

75 /100

Company Overview

JRNYS Wellness is a telemedicine company that provides personalized healthcare solutions focused on weight management, sexual health, and overall wellness. The platform connects patients with licensed medical providers for 100% online consultations, offering treatments that include GLP-1 medications (such as Zepbound, Mounjaro, Ozempic, and Wegovy), sildenafil (Viagra), and tadalafil (Cialis). In addition to prescribing medication, JRNYS offers personalized coaching for meal planning, goal setting, and behavioral support to ensure a holistic approach to health. Founded in 2022 by Dr. Henry Legere, the company aims to make healthcare more accessible and tailored to individual patient needs.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, D2C Brands, Patient Engagement, Subscription Commerce, Personalization

Business Model

B2C

Customer Profile

Subscription SaaS

AI Layer

Non-AI

Keywords

medical weight lossGLP-1 medicationtelemedicinecompounded semaglutideDTC healthcaresexual wellnesstelehealth platformED treatmentcompounded medicationOzempicWegovyMounjarosubscription healthcarehealth coachingcompounded tirzepatideinsurance navigation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

JRNYS Wellness Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

JRNYS Wellness Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Seed RoundApr 22, 2026
Series AJan 9, 2025

Key People

Founding team and executive leadership

Matt Kawadler

CEO

Executive Team

JRNYS Wellness Investors

Notable investors and investment history

InvestorRounds
Fourward VenturesSeries A
Afterburner CapitalSeries A
Capital FactorySeries A
MicroVenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 11, 2026

    Monthly visitors grew 132% MoM, reaching 46.7K.

  • Apr 22, 2026

    Raised $7.1M in a seed funding round.

JRNYS Wellness Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

JRNYS Wellness Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about JRNYS Wellness's valuation, stock price, and market status.

Firmographic Details

HeadquartersUnited States
Employee Range15
Year Founded2022
Last FundingApr 22, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.